股权激

Search documents
珍宝岛: 黑龙江珍宝岛药业股份有限公司2024年年度股东大会会议资料
Zheng Quan Zhi Xing· 2025-06-19 08:11
一、会议按照法律、法规、有关规定和《公司章程》的规定进行, 参会人员应自觉维护会议秩序。 二、股东参加股东大会,依法享有发言权、质询权、表决权等权 利,并应认真履行法定义务,不得侵犯其他股东的合法权益。 三、参会股东或股东代表应在2025年6月23日上午9时—11时,下 午14时—16时到黑龙江珍宝岛药业股份有限公司(以下简称"公司") 或者通过电子邮件等形式办理参会登记。已办理参会登记的股东及股 东代表需携带身份证明、股票账户卡、授权委托书等原件于2025年6 月25日下午13:55前到哈尔滨市平房开发区烟台一路8号办公楼办理 签到登记后参会。 四、股东提问应举手示意,并按照主持人的安排进行。发言及提 问前应先介绍自己的股东身份(或所代表的股东单位)、持股数量等 情况。发言及提问应围绕本次会议议案,每位发言时间不超过3分钟。 议案表决开始后将不再安排发言。 黑龙江珍宝岛药业股份有限公司 | 会 | 议 | | --- | --- | | 资 | | 料 议案 7:关于 2025 年向金融机构申请授信额度及融资的议案 .... 11 议案 9:关于董事、高级管理人员 2024 年度薪酬情况及 2025 年度薪 ...
为什么现在业务这么难做?投行大佬们总结出了一些实用建议
梧桐树下V· 2025-06-19 03:52
| 年中惠热销课程免费学 | 时长 | 原价 | The Dollea | | --- | --- | --- | --- | | | | | 5 折 | | 上市公司并购重组实务-2025年中惠专辑 | 12h | 899 | 449.5 | | 企业合规实务解析-2025年中惠专辑 | 12h | 899 | 449.5 | | 私募基金实务解析-2025年中惠专辑 | 13h | 799 | 399.5 | | 投行AI应用技巧-2025年中惠专辑 | 11h | 599 | 299.5 | | 企业并购重组实操专题(140案例) | 4.9h | 399 | 199.5 | | 上市公司控制权收购的15种方式 | 1h | 129 | 64.5 | | 并购交易精讲 | 2.7h | 269 | 134.5 | | 并购六条之后跨界并购实务与典型案例 | 1h | 88 | 44 | | 借壳上市与类借壳的模式解析 | 2h | 169 | 84.5 | | 上市公司并购重组审核7大法律要点 | 2.8h | 299 | 149.5 | | 企业出海全攻略 | 12h | 899 | 449.5 | ...
都市车界|广汽埃安辟谣“员工股权爆雷”:恶意谣言,已启动法律追责
Qi Lu Wan Bao· 2025-06-19 02:57
Core Viewpoint - The controversy surrounding GAC Aion's employee stock ownership plan has been exaggerated by some media outlets, leading to misinformation and damaging the brand's reputation, while highlighting the chaotic information dissemination in the current media landscape [1][15]. Group 1: Employee Stock Ownership Plan - The core issue of the employee stock ownership plan controversy lies in the malicious misinterpretation by some media outlets [2]. - GAC Aion's stock incentive plan has precedents, with a previous implementation in March 2023 covering 14% of employees and recognized as a benchmark case for state-owned enterprise reform [2]. - The company has clarified that the employee stock ownership plan is designed based on its development and capital market environment, and it is actively exploring various capital operation plans [2][4]. Group 2: Company Operations and Legal Actions - GAC Aion has stated that its operations are normal and that it has initiated legal actions against those spreading false rumors [4]. - The company has reported significant R&D investments, exceeding 7.9 billion yuan in 2024, with over 3,200 new patent applications [4]. - GAC Aion's solid-state battery research has entered the engineering prototype testing phase, achieving an energy density of over 400 Wh/kg, with plans for vehicle integration by 2026 [5]. Group 3: Market Position and Future Plans - GAC Aion is transitioning towards the consumer market, launching models like AION LX Plus and AION V Plus, while also planning to release new models in 2024 to enhance driving experience [6][7]. - The company has installed over 15,000 fast-charging stations across 202 cities in China, leading in charging network deployment [6]. - GAC Group aims to achieve a sales target of 2 million units for its self-owned brands by 2027, with GAC Aion playing a crucial role in this strategy [10]. Group 4: Financial Performance and Industry Challenges - GAC Group's total revenue for 2024 is projected to be approximately 106.79 billion yuan, reflecting a year-on-year decline of 17.05%, with a significant drop in net profit [13]. - The company faces dual pressures from declining sales in traditional joint venture brands and the competitive landscape of the new energy vehicle market [13]. - The ongoing challenges in the Chinese new energy vehicle market are exacerbated by external factors such as Tesla's upcoming Model 2 and new tariffs from the EU [13]. Group 5: Reform and Market Adaptation - GAC Aion's reform path represents a deep exploration of state-owned enterprises adapting to market competition, with various transformations since 2021 [14]. - The company has successfully attracted over 100 strategic investors during its A-round financing, indicating market confidence in its reform efforts [14]. - The narrative surrounding the controversy emphasizes the need for rational observation of reforms, as the company aims to enhance its value through stock incentives and strategic investments [14][16].
索菱股份: 关于注销2023年限制性股票与股票期权激励计划部分股票期权的公告
Zheng Quan Zhi Xing· 2025-06-18 13:23
Core Viewpoint - The company announced the cancellation of 650,000 stock options from its 2023 restricted stock and stock option incentive plan due to three incentive recipients leaving the company, which disqualified them from the plan [1][4][5]. Summary by Sections Approval Procedures - The company held meetings to review and approve various proposals related to the 2023 incentive plan, including the draft and management measures [1][2]. - Independent directors provided their opinions, and the supervisory board verified the incentive recipients [2][3]. Cancellation of Stock Options - The cancellation involves 650,000 stock options that were granted but not exercised by the three departing incentive recipients [4][5]. - This action was authorized by the third extraordinary general meeting of shareholders [4]. Impact on the Company - The cancellation of stock options is in compliance with relevant regulations and will not have a significant impact on the company's financial status or operational results [5]. Supervisory Board Opinion - The supervisory board agreed that the reasons and quantity for the cancellation align with legal and regulatory requirements [5]. Legal Compliance - The cancellation has received necessary approvals and adheres to the Company Law, Securities Law, and relevant management regulations [6].
索菱股份: 关于2022年限制性股票与股票期权激励计划预留授予部分第二个解除限售期解除限售条件及第二个行权期行权条件成就的公告
Zheng Quan Zhi Xing· 2025-06-18 13:23
证券代码:002766 证券简称:索菱股份 公告编号:2025-037 深圳市索菱实业股份有限公司 关于 2022 年限制性股票与股票期权激励计划 预留授予部分第二个解除限售期解除限售条件及第二个行权期行权 条件成就的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 重要内容提示: ? 股票期权可行权数量:7.50 万份;行权价格:4.25 元/份。 ? 本次行权和解除限售事宜需在有关机构办理相关手续结束后方可行权和 解除限售,届时公司将发布相关提示性公告,敬请投资者注意。 深圳市索菱实业股份有限公司(以下简称"公司")于 2025 年 6 月 17 日召 开了第五届董事会第二十次会议和第五届监事会第十八次会议,审议通过了《关 于 2022 年限制性股票与股票期权激励计划预留授予部分第二个解除限售期解除 限售条件及第二个行权期行权条件成就的议案》。现将有关事项说明如下: 一、股权激励计划简述及已履行的相关审批程序 (一)公司股权激励计划简述 司 2022 年限制性股票与股票期权激励计划(草案)>及其摘要的议案》等相关议 案,本激励计划的主要内容如下: 告本 ...
可立克: 上市公司股权激励计划草案自查表
Zheng Quan Zhi Xing· 2025-06-18 12:26
(是/否/不适用) 上市公司合规性要求 公司简称:可立克 股票代码:002782 是否存在该事项 序号 事项 备注 最近一个会计年度财务会计报告是否未被注册会计师出具否定意见或者 无法表示意见的审计报告 最近一个会计年度财务报告内部控制是否未被注册会计师出具否定意见 或无法表示意见的审计报告 上市后最近 36 个月内是否未出现过未按法律法规、公司章程、公开承诺 进行利润分配的情形 激励对象合规性要求 是否未包括单独或合计持有上市公司 5%以上股份的股东或实际控制人及 其配偶、父母、子女 是否最近 12 个月内未因重大违法违规行为被中国证监会及其派出机构行 政处罚或者采取市场禁入措施 激励计划合规性要求 上市公司全部在有效期内的股权激励计划所涉及的标的股票总数累计是否未 超过公司股本总额的 10% 单一激励对象通过全部在有效期内的股权激励计划累计获授股票是否未超过 公司股本总额的 1% 激励对象为董事、高管的,股权激励计划草案是否已列明其姓名、职务、获 授数量 激励对象为董事、高管的,是否设立绩效考核指标作为激励对象行使权益的 条件 股权激励计划披露完整性要求 (1)对照《股权激励管理办法》的相关规定,逐条说明 ...
东阿阿胶: 第十一届监事会第八次会议决议公告
Zheng Quan Zhi Xing· 2025-06-18 11:08
Group 1 - The supervisory board meeting was held on June 15, 2025, and the notice was sent via email [1] - The supervisory board approved the adjustment of the first phase of the restricted stock incentive plan, confirming it aligns with relevant regulations and does not harm shareholder interests [1] - The adjusted incentive objects meet the conditions set forth in the management measures and the incentive plan [1] Group 2 - The supervisory board agreed that the initial grant date of June 18, 2025, complies with the management measures and the incentive plan [2] - A total of 984,043 restricted shares will be granted to 176 eligible incentive objects at a price of 35.95 yuan per share [2] - The approval vote was unanimous with 5 votes in favor, 0 against, and 0 abstentions [2]
派诺科技: 第五届监事会第二十次会议决议公告
Zheng Quan Zhi Xing· 2025-06-18 10:45
证券代码:831175 证券简称:派诺科技 公告编号:2025-067 珠海派诺科技股份有限公司 (一)审议通过《关于公司 2025 年股权激励计划权益首次授予相关事项的议案》 根据《上市公司股权激励管理办法》《北京证券交易所上市公司持续监管指 引第 3 号——股权激励和员工持股计划》等法律法规、规章和规范性文件及公司 《2025 年股权激励计划(草案)》的相关规定,本次股权激励计划无获授权益条 件,公司董事会根据公司 2025 年第三次临时股东会的决议和授权,同意首次向 日为 2025 年 6 月 17 日。 具体内容详见公司于 2025 年 6 月 18 日在北京证券交易所官方信息披露平台 (www.bse.cn)上披露的公司《2025 年股权激励计划权益首次授予公告》 (公告编 本次监事会的通知时间、召集人等均符合《公司法》等有关法律法规及《公 司章程》的规定,不需要再经其他部门批准,不需要再履行其他手续。 (二)会议出席情况 会议应出席监事 3 人,出席和授权出席监事 3 人。 二、议案审议情况 本公司及监事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的 ...
泰慕士: 关于部分限制性股票回购注销完成的公告
Zheng Quan Zhi Xing· 2025-06-18 10:45
Core Viewpoint - Jiangsu Taimusi Textile Technology Co., Ltd. has completed the repurchase and cancellation of 20,000 restricted stocks, which accounts for approximately 0.02% of the company's total share capital before the repurchase [1][3][4]. Summary by Sections 1. Stock Repurchase and Cancellation - The company has approved the repurchase and cancellation of 20,000 restricted stocks due to one incentive object losing eligibility after leaving the company [3][4]. - The repurchase price is set at RMB 8.94 per share plus the interest from the People's Bank of China, totaling RMB 179,933.54 for the repurchase [4][5]. 2. Impact on Share Capital Structure - After the repurchase, the total share capital will decrease from 109,433,700 shares to 109,413,700 shares [6]. - The structure of shares will change slightly, with limited sale condition shares decreasing from 18,064,000 (16.51%) to 18,044,000 (16.49%), while unrestricted shares will increase from 91,369,700 (83.49%) to 91,369,700 (83.51%) [6]. 3. Financial Impact - The repurchase and cancellation of restricted stocks will not have a substantial impact on the company's financial status or operating results, nor will it harm the interests of the company and all shareholders [6]. - The management team will continue to fulfill their responsibilities to promote the company's sustainable development and create value for shareholders [6].
万孚生物: 北京市君合(广州)律师事务所关于广州万孚生物技术股份有限公司终止实施2024年限制性股票激励计划暨回购注销限制性股票的法律意见书
Zheng Quan Zhi Xing· 2025-06-18 09:28
Core Viewpoint - Guangzhou Wanfu Biological Technology Co., Ltd. has decided to terminate the implementation of the 2024 restricted stock incentive plan and to repurchase and cancel the restricted stocks involved in the plan due to significant changes in the internal and external business environment, which have led to discrepancies between expected operational conditions and the assessment criteria set in the incentive plan [1][8]. Group 1: Authorization and Approval - The company has completed necessary procedures for the termination and repurchase, including resolutions from the board of directors and supervisory board, and has disclosed relevant announcements [4][8]. - The company’s supervisory board did not receive any objections during the public notice period regarding the list of incentive objects [5]. Group 2: Specifics of Termination and Repurchase - The company will repurchase a total of 10.544 million shares of restricted stock, which were granted but not yet released from restrictions [8]. - The repurchase price is set at 12.42 yuan per share plus the interest from bank deposits at the same period [8]. - The funding for the repurchase will come from the company's own funds [8]. Group 3: Legal Compliance and Impact - The termination and repurchase comply with relevant laws and regulations, including the Company Law and Securities Law, and will not significantly impact the company's operations or shareholder rights [9].